Eilean Therapeutics clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-14
What changed in the last 30 days
3 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 1 with a minor change only.
- Notable: ZE74-0282 · JAK2 V617F- or Calreticulin-Mutated Hematologic Disorders Recruitment opened
- Minor: ZE63-0302 Administrated Orally in T2DM Patients Trial completed
- Notable: ZE66-0205 in Healthy Volunteers Recruitment opened
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 3 |
Disease areas by active trials
Glioblastoma (1) · Glioma (1) · Myelofibrosis (1)
Get alerts when Eilean Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.